234 related articles for article (PubMed ID: 27130233)
1. Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using
Verhelle A; Van Overbeke W; Peleman C; De Smet R; Zwaenepoel O; Lahoutte T; Van Dorpe J; Devoogdt N; Gettemans J
Mol Imaging Biol; 2016 Dec; 18(6):887-897. PubMed ID: 27130233
[TBL] [Abstract][Full Text] [Related]
2. Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model.
Van Overbeke W; Verhelle A; Everaert I; Zwaenepoel O; Vandekerckhove J; Cuvelier C; Derave W; Gettemans J
Mol Ther; 2014 Oct; 22(10):1768-78. PubMed ID: 25023329
[TBL] [Abstract][Full Text] [Related]
3. An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model.
Van Overbeke W; Wongsantichon J; Everaert I; Verhelle A; Zwaenepoel O; Loonchanta A; Burtnick LD; De Ganck A; Hochepied T; Haigh J; Cuvelier C; Derave W; Robinson RC; Gettemans J
Hum Mol Genet; 2015 May; 24(9):2492-507. PubMed ID: 25601851
[TBL] [Abstract][Full Text] [Related]
4. Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant.
Giorgino T; Mattioni D; Hassan A; Milani M; Mastrangelo E; Barbiroli A; Verhelle A; Gettemans J; Barzago MM; Diomede L; de Rosa M
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):648-660. PubMed ID: 30625383
[TBL] [Abstract][Full Text] [Related]
5. AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model.
Verhelle A; Nair N; Everaert I; Van Overbeke W; Supply L; Zwaenepoel O; Peleman C; Van Dorpe J; Lahoutte T; Devoogdt N; Derave W; Chuah MK; VandenDriessche T; Gettemans J
Hum Mol Genet; 2017 Apr; 26(7):1353-1364. PubMed ID: 28334940
[TBL] [Abstract][Full Text] [Related]
6. The role of gelsolin domain 3 in familial amyloidosis (Finnish type).
Zorgati H; Larsson M; Ren W; Sim AYL; Gettemans J; Grimes JM; Li W; Robinson RC
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):13958-13963. PubMed ID: 31243148
[TBL] [Abstract][Full Text] [Related]
7. The 8 and 5 kDa fragments of plasma gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68 kDa fragment is not amyloidogenic.
Solomon JP; Yonemoto IT; Murray AN; Price JL; Powers ET; Balch WE; Kelly JW
Biochemistry; 2009 Dec; 48(48):11370-80. PubMed ID: 19904968
[TBL] [Abstract][Full Text] [Related]
8. Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention.
Solomon JP; Page LJ; Balch WE; Kelly JW
Crit Rev Biochem Mol Biol; 2012; 47(3):282-96. PubMed ID: 22360545
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.
Kennel SJ; Stuckey A; McWilliams-Koeppen HP; Richey T; Wall JS
Mol Imaging Biol; 2016 Aug; 18(4):483-9. PubMed ID: 26573301
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.
Zheng F; Put S; Bouwens L; Lahoutte T; Matthys P; Muyldermans S; De Baetselier P; Devoogdt N; Raes G; Schoonooghe S
J Nucl Med; 2014 May; 55(5):824-9. PubMed ID: 24686780
[TBL] [Abstract][Full Text] [Related]
11. Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.
Schmidt EK; Kiuru-Enari S; Atula S; Tanskanen M
Amyloid; 2019 Sep; 26(3):118-124. PubMed ID: 31122115
[No Abstract] [Full Text] [Related]
12. Ca2+ binding protects against gelsolin amyloidosis.
Page LJ; Huff ME; Kelly JW; Balch WE
Biochem Biophys Res Commun; 2004 Oct; 322(4):1105-10. PubMed ID: 15336957
[TBL] [Abstract][Full Text] [Related]
13. Cutis laxa in hereditary gelsolin amyloidosis.
Kiuru-Enari S; Keski-Oja J; Haltia M
Br J Dermatol; 2005 Feb; 152(2):250-7. PubMed ID: 15727635
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular pathology in hereditary gelsolin amyloidosis.
Kiuru-Enari S; Somer H; Seppäläinen AM; Notkola IL; Haltia M
J Neuropathol Exp Neurol; 2002 Jun; 61(6):565-71. PubMed ID: 12071640
[TBL] [Abstract][Full Text] [Related]
15. Metalloendoprotease cleavage triggers gelsolin amyloidogenesis.
Page LJ; Suk JY; Huff ME; Lim HJ; Venable J; Yates J; Kelly JW; Balch WE
EMBO J; 2005 Dec; 24(23):4124-32. PubMed ID: 16281052
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
17. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome.
Kivelä T; Tarkkanen A; Frangione B; Ghiso J; Haltia M
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3759-69. PubMed ID: 8088963
[TBL] [Abstract][Full Text] [Related]
18. Severe elastolysis in hereditary gelsolin (AGel) amyloidosis.
Koskelainen S; Zhao F; Kalimo H; Baumann M; Kiuru-Enari S
Amyloid; 2020 Jun; 27(2):81-88. PubMed ID: 31814469
[TBL] [Abstract][Full Text] [Related]
19. Fibrillogenesis in gelsolin-related familial amyloidosis.
Maury CP; Nurmiaho-Lassila EL; Boysen G; Liljeström M
Amyloid; 2003 Aug; 10 Suppl 1():21-5. PubMed ID: 14640038
[TBL] [Abstract][Full Text] [Related]
20. Gelsolin domain 2 Ca2+ affinity determines susceptibility to furin proteolysis and familial amyloidosis of finnish type.
Huff ME; Page LJ; Balch WE; Kelly JW
J Mol Biol; 2003 Nov; 334(1):119-27. PubMed ID: 14596804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
